| Abstract | Taxol is an important new antitumor agent with demonstrated efficacy in ovarian and breast cancer. Toxicities identified, including cardiac, hypersensitivity reactions, and neurologic, require careful nursing assessment for management, Additional toxicities may be identified as Taxol is combined with other chemotherapeutic agents. Studies to determine the most effective dose and schedule are ongoing. The current evaluation of this new drug presents an important opportunity for nurses to contribute to its development through both clinical and research endeavors. Such contributions will facilitate the optimal nursing care of patients treated with Taxol. |
| Authors | M H Noone, M S McCabe, A M Denicoff, J M Lepore
(Affiliation: Medicine Branch, National Cancer Institute, Bethesda, MD 20892.)
|
| Journal | Journal of the National Cancer Institute. Monographs
(J Natl Cancer Inst Monogr)
Issue 15
Pg. 149-54
( 1993)
ISSN: 1052-6773 UNITED STATES |
| PMID | 7912521
(Publication Type: Journal Article, Review)
|
| Chemical References |
|
| Topics |
- Humans
- Neoplasms
(drug therapy, nursing)
- Nursing Assessment
- Paclitaxel
(adverse effects, therapeutic use)
- Patient Education as Topic
|
